Alector, Inc (ALEC)

Etorro trading 970x250
Alector, Inc (ALEC) Logo

About Alector, Inc

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer’s and Parkinson’s diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer’s disease; and AL003, which is in Phase Ib clinical trial for the treatment of Alzheimer’s disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer’s disease; and 8 candidates in immuno-neurology/immuno-oncology field comprise ADP012, ADP016, ADP017, ADP023, ADP026, ADP122, ADP009, and ADP022. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies. The company was founded in 2013 and is headquartered in South San Francisco, California. Address: 131 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

Alector, Inc News and around…

Latest news about Alector, Inc (ALEC) common stock and company :

Those who invested in Alector (NASDAQ:ALEC) a year ago are up 134%
04 Oct, 2021 Yahoo! Finance

Alector, Inc. ( NASDAQ:ALEC ) shareholders might understandably be very concerned that the share price has dropped 33...

12 Health Care Stocks Moving In Thursday's After-Market Session
30 Sep, 2021 FinancialContent

Gainers FibroGen (NASDAQ:FGEN) stock moved upwards by 4.99% to $10.73 during Thursday's after-market session. The company's market ...

Alector Announces Appointment of Elizabeth A. Garofalo, M.D., to its Board of Directors
28 Sep, 2021 FinancialContent
Chief Executive Officer Of Alector Sold $2.77 Million In Stock
24 Sep, 2021 FinancialContent

Arnon Rosenthal, Chief Executive Officer at Alector (NASDAQ:ALEC), made a large insider sell on September 23, according to a new SEC ...

Noteworthy ETF Inflows: XBI, XLRN, ALEC, CYTK
24 Sep, 2021 FinancialContent

Symbols mentioned in this story: XBI, XLRN, ALEC, CYTK Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand..

Alector Announces First Participant Dosed in Phase 2 Study Evaluating AL001 in Amyotrophic Lateral Sclerosis (ALS)
09 Sep, 2021 FinancialContent
54 Biggest Movers From Yesterday
09 Sep, 2021 FinancialContent

Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on ...

Why Alector Shares Are Diving Today
08 Sep, 2021 FinancialContent

There has been a major shakeup in the C-suite.

Mid-Afternoon Market Update: Kadmon Surges Following Acquisition News; UiPath Shares Drop
08 Sep, 2021 FinancialContent

Toward the end of trading Wednesday, the Dow traded down 0.24% to 35,015.62 while the NASDAQ fell 0.61% to 15,280.10. The S&P also ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
08 Sep, 2021 FinancialContent

Gainers Kadmon Holdings (NASDAQ:KDMN) shares increased by 72.64% to $9.15 during Wednesday's regular session. ...

Mid-Day Market Update: Crude Oil Rises 1%; REV Group Shares Plummet
08 Sep, 2021 FinancialContent

Midway through trading Wednesday, the Dow traded down 0.45% to 34,942.88 while the NASDAQ fell 1.09% to 15,207.45. The S&P also ...

30 Stocks Moving In Wednesday's Mid-Day Session
08 Sep, 2021 FinancialContent

Gainers Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New ...

Mid-Morning Market Update: Markets Mixed; Korn Ferry Reports Upbeat Q1 Results
08 Sep, 2021 FinancialContent

Following the market opening Wednesday, the Dow traded up 0.03% to 35,111.48 while the NASDAQ fell 0.27% to 15,332.05. The S&P also ...

How The Pieces Add Up: ESML Headed For $47
08 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares ESG Aware MSCI USA Small-Cap ETF (ESML), we found that the implied analyst target price for the ETF based upon its underlying holdings is $46.57 per unit.

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
08 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Alector Provides Executive Leadership Update
07 Sep, 2021 FinancialContent
Alector to Present at Upcoming Virtual Healthcare Conferences
02 Sep, 2021 FinancialContent
Alector Becomes Oversold (ALEC)
20 Aug, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Analysts Just Made A Substantial Upgrade To Their Alector, Inc. (NASDAQ:ALEC) Forecasts
05 Aug, 2021 Yahoo! Finance

Shareholders in Alector, Inc. ( NASDAQ:ALEC ) may be thrilled to learn that the analysts have just delivered a major...

Alector (ALEC) Reports Q2 Loss, Lags Revenue Estimates
03 Aug, 2021 Yahoo! Finance

Alector (ALEC) delivered earnings and revenue surprises of 0.00% and -26.41%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Alector Reports Second Quarter 2021 Financial Results
03 Aug, 2021 FinancialContent
Analysts Estimate Alector (ALEC) to Report a Decline in Earnings: What to Look Out for
03 Aug, 2021 Yahoo! Finance

Alector (ALEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts See 10% Upside For The Holdings of ESGV
03 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard ESG US.

12 Health Care Stocks Moving In Monday's After-Market Session
02 Aug, 2021 FinancialContent

Gainers F-star Therapeutics (NASDAQ:FSTX) stock rose 9.3% to $5.99 during Monday's after-market session. The company's market cap ...

70 Biggest Movers From Yesterday
30 Jul, 2021 FinancialContent

Gainers Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares surged 65.1% to settle at $5.30 on Thursday. Xenetic Biosciences recently ...

Alector Stock Falls After Flashing 12-Month Data From Mid-Stage Trial In Frontotemporal Dementia Patients
29 Jul, 2021 FinancialContent

Alector Inc(NASDAQ: ALEC)detailed early datafrom its lead drug, AL001, INFRONT-2 Phase trial at the Alzheimer's ...

12 Health Care Stocks Moving In Thursday's Intraday Session
29 Jul, 2021 FinancialContent

Gainers NanoVibronix (NASDAQ:NAOV) shares moved upwards by 38.21% to $2.64 during Thursday's regular session. Trading volume for ...

Alector Presents 12-Month Results from the INFRONT-2 Phase 2 Open-label Clinical Study of AL001 for the Treatment of Symptomatic Frontotemporal Dementia Patients with a Progranulin Mutation
29 Jul, 2021 FinancialContent
3 Best Dividend Stocks To Buy With Yields Of More Than 5%
29 Jul, 2021 FinancialContent

Dividend paying companies with stable fundamentals are prominent bets now considering the market’s high volatility. Established stocks AT&T Inc., Vale S.A, and GlaxoSmithKline, each currently yield more than 5%.

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
29 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Alector, Inc (ALEC) is a NASDAQ Common Stock listed in , ,

970x250